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Understanding 
Product Life Cycle 
    Define position within the Product Life Cycle 
 Each stage has Barrier Gate to the next level 
 Each Gate exponentially transforms complexity 
from Technical issues to Commercial 
 Time to Market is limited and may collapse 
 Market Entry Gate is most volatile and where the 
“Valley of Death” is most prominent 
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Process Scale-up 
Nanotechnology researchers skill set quickly becomes tested as 
complexity expands outside the product into business and facilities. 
Lab scale 
Kilo Lab 
Pilot Plant 
Manufacturing plant 
C
o
st
 
Time 
Nano-PM provides needed expertise in material science, process expansion, 
regulatory compliance, facility scoping, budgeting, and schedules. 
   
Nanotechnology 
Scale-up to  
Commercialization 
“One to a Million” 
 
 Applications of the Nanomaterial 
 Identify End Products 
 Define Customers 
 Technical Competition,   
 both nano and current technology. 
 Size of current market, market growth 
and useful life (obsolescence) 
 Unit Sale Price vs. Cost to Produce – 
current versus projected (estimated) 
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Market Potential 
• Short term 
• Medium term 
• Long term 
Understanding 
Markets and Products  
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Understanding 
Readiness to Proceed 
Nano-PM  
Readiness  
Survey 
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Understanding: 
• Position in Product Life Cycle 
• Market and Product 
• Readiness Scoring 
Allows transition to next 
step- Information Gathering 
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Information 
Production Equipment - Lab to Plant 
Scale-up of Equipment 
• Full Equipment Set Defined 
• Throughput and Reliability 
• Costs and Options 
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Identify Grams to Tons Requirement 
   The “One to a Million” 
Early Equipment Validation Trials 
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Information 
Toxicity and EHS Testing 
• Extensive product Testing  
• Safety of Product during production 
• Safety of Product for Use 
• Long Term Impact on Health 
• Impact on Environment 
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NanoTox 
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Information 
Governmental Compliance 
• Global Governmental Regulations  
• International Standards for Nano 
• Transportation Restrictions 
• Evaluate ISO Standard 13121 
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Governmental Regulations 
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Information 
Testing and Pilot 
Pending Informational Issues found- 
• Run Equipment Pilots for Scale-up with 
Equipment Vendors 
• Mitigation methods test for EHS issues 
• Trial runs of products 
• Pilot test of governmental approval 
• Test batch transport and logistics 
issues 
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Plan for Testing of Risks 
Pilot Production  
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Information 
Gathering Data for Informed Decisions 
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Information Gathering on: 
• Production Equipment 
• Toxicity and EHS 
• Governmental Regulations 
• Testing and Pilots 
Allows transition to next step: 
Implementation of a Clear Strategy and  
Program Execution Plan 
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Implementation 
developing a Program Execution Plan  
 Program Execution Plan 
 Executive Summary 
 Program Description 
 Technology 
 Product Positioning 
 Life of product and obsolescence 
 Usage and commercial viability 
 Geographic positioning of market 
 Geographic optimization of manufacturing 
 Phasing Plan and Schedules 
 Financing, Budgets and Costing 
 Organization and Resources 
 Risks 
 EHS 
 Quality 
 Administration and Governance 
 Operations 
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Implementation 
Insurers & Risk Management 
Alignment of Risk Stakeholders 
 Information stage collected data focused 
on Insurer requirements 
 Questionnaire for Readiness focuses on key 
risk and insurance issues 
 Product manufacturing EHS risks – captured by 
NanoTox and toxicity testing 
 Long term Liabilities focused on end products 
 Insurance Partners included in plan 
 Risk Management  
Program Execution Planning  
 Captures all risk elements and how either 
insured or mitigated 
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Implementation 
Incorporating Investors 
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Alignment of Financial Stakeholders 
 Information stage collected data focused 
on investor risk issues. 
 Questionnaire for Readiness defines areas of 
potential market revenue, costs, viability 
 Information stage develops equipment cost, 
detail capital needs, phasing of budgets  
 Business Model and projections 
 Investment Partners included in plan 
 Banks, Venture Capital, Funding 
Program Execution Planning  
 Captures financial model for budgets, cash 
flow, sources of funding, financial controls 
and governance 
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Implementation 
Governments and Logistics 
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Alignment of External Stakeholders 
 Information stage collected data focused 
on external positive or negative influences. 
 Questionnaire for Readiness outlines 
geographic areas, governmental and 
community support and or regulations 
 Information stage develops detail of regulatory 
environment and risks to product development 
 Information stage outlines community, supplier, 
or customer support or resistance 
 Governmental issues and Logistics 
Providers included in plan 
Program Execution Planning  
 Captures influence in various sections of 
Risk, Financing, Schedule restraints, etc. 
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Checkpoint: 
Change and Flexibility in Planning 
Technology and Innovation Fact: 
Constant Change in Conditions- 
Plans can be outdated immediately! 
Establish: 
 Lessons Learned at each step 
 Change Management 
 Know when you are changing 
 Know when to stop changing 
 Know when change is necessary 
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Questions      
Process Steps for Commercialization  
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Following the Steps: 
• Understanding 
• Information Gathering 
• Implementation Planning 
 Allows small steps and clear investment of 
resources to get to the next level 
 Reduces risks in each step 
 Challenges Plans based on data 
 Includes Stakeholders in Final Plan 
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Thank You! 
 
Contact: 
 
Nano-PM 
 
Dan Bassett   Colorado   DanBassett@Nano-PM.com   
Bob Predmore    Arizona    BobPredmore@Nano-PM.com 
Harry Bushong  Texas    hbushong@nanotox.com 
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Backup Information 
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Preliminary Business Risk Matrix  
    Technology  
Review 
    Estimate (s)   
Development 
   Risk Matrix & 
 Business Plan 
 
 Capital Cost Estimate 
 Life Cycle 
 Raw Materials 
 Engineering 
 Labor Study 
 Priced Equipment List 
 Materials Takeoff/ 
Pricing 
 Site General Conditions 
 Range Estimating 
 Estimate Reviews 
 Sales Price 
 Capacity Requirements 
 Net Present Worth 
 Depreciation 
 Internal Rate of Return 
 Working Capital 
 
 Value engineering (2) 
 PSM support 
 Debottlenecking 
Issues 
 Hazard analysis 
 SHE issues 
 Constructability (2) 
 Cost benefit analysis 
 Time to Market 
 Phasing Plans 
 ROI Analysis 
 
 
Facility & Ops 
Questionnaire 
 
 Production Equipment 
Layout plot plans 
 Major Manufacturing 
Equipment 
 Design Criteria 
 Life Safety Analysis 
 Specialized HVAC 
Systems 
 Building Architecture  
 Special Piping 
/Plumbing 
 Electrical 
 Controls 
 Security 
 Environmental 
 Materials of 
Construction 
 
Kickoff 
 
 
 Submit Questionnaire 
 Strategic dates 
 Master project schedule 
Develop WBS 
 Production startup 
schedule  
 Team  Coordination 
(Responsibility Matrix) 
 Owner supplied info 
 Location  
 Black box equipment 
info 
 Code studies/permits 
 SHE status 
 Product Validity 
 Site visits 
 Initial Funding 
 
 Status of Lab Studies 
 Rate Controlling Steps 
 Life Safety Analysis 
 Scale up Studies  
 Product Stability 
 Product Uniformity 
 Raw Material Quality 
 Process Modeling 
 Turndown Ratio 
 Nameplate Capacity 
 Number of Trains 
 Storage of Product 
 Storage of Raw 
Materials 
 Environmental  
 Design Criteria 
 
 
Our proposed initial step is to conduct a questionnaire matrix to determine the 
Technical and Business readiness to assist new Nano scale-up planning  
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Project Management Gate Process 
1.0 
Business 
Planning 
2.0 
Concept Facility       
Planning 
3.0 
Front End Design 
4.0 
Project       
Execution 
5.0 
Operation & 
Evaluation 
 Business Need 
 Project Sponsor 
 Steering Team 
 Project Charter 
 Sales Forecast 
 Sourcing Alternatives 
 Target Site 
 Technology Alternatives & 
Assessments 
 Legal & Environmental 
 Concept Designs Options 
 Operate & Maintain 
 Milestone Schedule 
 ROM estimate (+/-50%) 
 ROI Analysis 
 Economic Evaluation of 
Alternatives 
 Final Site Selection 
 Conceptual Design Scope 
Including Flow Sheets 
 Preliminary Project 
Execution Plan 
 VAR–Value Added Record 
 Risk Analysis 
 Resource Commitments 
 Readiness Review 
 Master Schedule 
 Conceptual Estimate (+/-
30%) 
 Project Design Basis 
 Project Execution Plan 
 Validation Master Plan 
 Long Lead Equipment 
Order Placement 
 Frozen Scope Document 
 Facility Acceptance 
Criteria 
 Risk Assessments 
 Project Review 
 Peer Review 
 3rd Party estimate Review 
 Project Baseline Schedule 
 CR Estimate (+/-10%) 
1 2 3 
Decision  
Gate Reject or 
Recycle 
Approve 
Decision  
Gate Reject or 
Recycle 
Approve 
Decision  
Gate Reject or 
Recycle 
Approve 
Initial Capital Request  ► Supplemental request  ► Full Funding Request   ► 
On completion of the Risk Matrix the focus will be to provide services for: 
Business(1.0) & Facility Plan (2.0) then Owner’s Representation for (3.0-5.0)     
 Stability Tests 
 Performance 
 Benchmark 
 Certification or 
Accreditation 
 Project Close-out 
 Share Lessons Learned 
 Identify Improvement 
Opportunities 
Reject or 
Recycle 
Decision  
Gate 
Approve 
Turn over to Operations 4 5 
Decision  
Gate Reject or 
Recycle 
 Environmental / 
Construction Permits 
 Implement Project 
Controls to baselines 
 Execution Contract 
Awards 
 Completed Engineering 
Work Packages 
 Completed Construction 
& Equipment Install 
 Construction & 
Equipment  
 Start-Up and 
Commissioning 
 Owner Operations Move-
In 
Approve 
Design  / Build     ► 
MAJOR DELIVERABLES 
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Owners Rep Scope of Project Services 
    Design 
4.0 
    Construction 
4.0 
  Operations & 
       Maintenance 5.0 
 Feasibility studies 
 Evaluation of alternatives 
 Conceptual cost estimating 
 Technology development  
 Technology scale-up 
 Process simplification 
 Project economic analysis 
 Site selection 
 Environmental assessments 
 PSM permitting–HAZOPS 
 Dynamic simulation analysis 
 Process engineering design 
 Detailed engineering 
 Equipment design 
 Facilities design 
 Instrumentation / Automation 
 Systems integration 
 CADD 
 Reliability analysis 
 Value engineering 
 Constructability reviews 
 Operability studies / manuals 
 Environmental and 
permitting assistance 
 Safety management 
 Planning and scheduling 
 Constructability 
 Labor relations/hiring 
 Community relations 
 Craft training 
 On-site materials 
management 
 Site security 
 Productivity management 
 Quality assurance 
 Field engineering 
 Prefabricate/Modularize 
 Mechanical integrity–PSM 
 Construction support 
facilities 
 Facility turnover/ 
commissioning 
 Plant operations 
 Maintenance/modifications 
 Facilities management 
 Operations training/start-up 
support 
 Predicative maintenance 
 PSM support 
 Contract maintenance 
 Warehouse management 
 Facility management 
 Debottlenecking 
 Safety 
programs/management 
 Asbestos/lead abatement 
 Non destructive testing 
 Shutdown/outage planning 
 Environmental assessment 
 Environmental permitting 
assistance  
 Asset retirement  
 
    Procurement 
4.0 
 Global sourcing 
 Shop evaluations 
 Requisitioning/bid 
conditioning 
 Contracts negotiations 
 Vendor surveillance 
 Logistics 
 Expediting 
 Quality assurance 
 Vendor document control 
 Warranty/service 
management 
 Supply chain management 
 
 
 
Front 
End  
3.0 
 Estimate 
 Master project schedule 
 Process flow diagrams 
 Utility summary 
 Utility flow diagrams 
 Waste handling requirements 
 Interlock classifications and 
descriptions 
 Instrument list 
 Piping requirements 
 Special fittings list 
 Building & site requirements 
 Equipment arrangements 
and plot plans 
 Power distribution plan 
 Area electrical classification 
 Process descriptions 
 Detailed process control 
descriptions 
 Process control hardware 
description 
 Control system functional 
description 
Project Oversight is needed in the downstream execution steps as the 
Nanomaterial supplier & Nanomaterial purchaser move forward 
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Risk Management Highlights Challenges 
IDENTIFY 
• Risk-based 
Questionna
ire 
• Brainstorm
ing 
• Experience 
• Ad Hoc 
Risks 
QUANTIFY 
Quantifies Risks: 
• Relational analysis 
• Probability of  
   Occurrence (RP) 
• Impact of  
   Occurrence (RI) 
Risk  
Exposure 
Risk 
Exposure 
is Low 
STRATEGIZE 
Risk Mitigation 
Strategy 
Monitors 
Contingency 
(RI) 
(RP) 
Risk Watch 
List 
Risk 
 Exposure 
Is High or 
Moderate 
Risk Database 
Risk Has 
Been 
Mitigated 
Contract 
Master 
Schedule 
MITIGATION 
IPT Implements 
Mitigation Strategy 
Our Risk Management Process to Identify, Quantify, Strategize and Minimize 
 Risks, starts early and is continuous along  the entire project lifecycle 
23 
   
Nanotechnology 
Scale-up to  
Commercialization 
“One to a Million” 
 
24 
drop down lists, please select other and place a short answer in the text 
block provided. 
1. Name of the Person Completing this Survey  
 
(Provide two responses.) 
 
2. Street Address  
 
[          ]  
 
3. Country or Region of Your Research or Business  
 
(Select all that apply.) 
 
[ ]Abu Dhabi  
 
[ ]Albania  
 
[ ]Andora  
 
[ ]Argentina  
 
  
32. 1.12.4 Uptime Factor - Identify potential causes of downtime and 
there frequency i.e. cleaning equipment, maintenance, etc  
 
33. 1.12.5 Technology Alternatives - Define list of alternative 
technologies explored in the development process  
 
34. 1.12.6 Ide tify Strategic Dates - Identify the key dates to get 
product developed and to market  
 
35. 1.13 Product Specifics - Define the chemical name, and chemical 
makeup of the product  
 
36. 1.13.1 Product Stability - What is the product shelf life  
 
37. 1.13.2 Product Sales Price - Define the estimated sales price in $/lb 
or similar currency  
 
38. 1.13.3 Product Raw Materials Cost - Identify all known aspects of 
current raw materials and their availability  
 
 
 
285. 
Sub Question: Raw Material #2 Select Unit of Weight Measure in 
this window. It will then skip to where the quantity or actual 
we gh  should be enter d.  
 
( )grams (Skip to Q. 286)  
 
( )kilograms (Skip to Q. 286)  
 
( )ounce (Skip to Q. 286)  
 
( )lbs (Skip to Q. 286)  
 
( )tonne (Skip to Q. 286)  
 
( )ton (us) (Skip to Q. 286)  
 
286. 
Sub Question: Raw Material #2 According to Weight Measure 
Selected in Prior Window  
 
[          ]  
 
287. 
If you plan on multiple product lines what Percentages of 
Production volume for each planned industrial function of the 
Nanomaterial. Product Line #1  
 
( )Product Line #1 (Skip to Q. 288)  
 
288. 
Product Line #1 Percentage (Combined selections shall equal 
100%)  
 
[          ]  
 
 
407. 
Are procedures communicated to customers in order to inform 
them on how to safely use, dispose of, or recycle the product 
and manage environmental, health, and safety risks?  
 
( )Yes  
 
( )No  
 
( )Not Yet  
 
( )Not Applicable  
 
408. 
Do labels and other safety-information communications indicate 
the extent of harm that could result from reasonably 
foreseeable misuse?  
 
( )Yes  
 
( )No  
 
( )Not Yet  
 
( )Not Applicable  
 
409. 
Does packaging comply with transportation and risk 
regulations? Are workers and customers throughout the 
lifecycle adequately informed and protected?  
 
( )Yes  
 
( )No  
 
( )Not Yet  
 
( )Not Applicable  
 
410. Is the environment protected from the identified hazards?  
 
( )Yes  
 
( )No  
 
( )Not Yet  
 
( )Not Applicable  
 
411. Are warnings (if applicable) available throughout the product 
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This new tool allows you to search the U.S. state by state to locate nanotechnology-related facilities,  
